| Issue Date | Title | Author(s) |
| 2008 | Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo | Ruan, Guo-Rui; Zhao, Hong-Shan; Chang, Yan; Li, Jin-Lan; Qin, Ya-Zhen; Liu, Yan-Rong; Chen, Shan-Shan; Huang, Xiao-Jun |
| 2007 | Analysis of leukemia associated immunophenotype (LAIP) in 610 patients with acute myeloid leukemia and their significant in minimal residual disease detection | Liu, Yan-rong; Wang, Ya-zhe; Chang, Yan; Chen, Shan-Shan; Fu, Jia-yu; Wang, Hui |
| 2014 | The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma | Zhang, Yao; Bao, Li; Lu, Jin; Liu, Kai-Yan; Li, Jin-Lan; Qin, Ya-Zhen; Chen, Huan; Li, Ling-Di; Kong, Yuan; Shi, Hong-Xia; Lai, Yue-Yun; Liu, Yan-Rong; Jiang, Bin; Chen, Shan-Shan; Huang, Xiao-Jun; Ruan, Guo-Rui |
| 2011 | Imatinib Mesylate Is Superior to Allogeneic Hematopoietic Stem Cell Transplantation As the First-Line Therapy for Patients with Chronic Myeloid Leukemia in the Early Chronic Phase | Jiang, Qian; Xu, Lan-Ping; Liu, Dai-Hong; Liu, Kai-Yan; Jiang, Bin; Zhang, Xiao-hui; Wang, Yu; Chen, Shan-Shan; Mo, Xiao-Dong; Zhao, Xiang-Yu; Chen, Huan; Chen, Yu-Hong; Han, Wei; Jiang, Hao; Qin, Ya-Zhen; Liu, Yan-Rong; Lai, Yue-yun; Shi, Hong-Xia; Lv, Meng; Huang, Xiao Jun |
| 2011 | Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase | Jiang, Qian; Xu, Lan-Ping; Liu, Dai-Hong; Liu, Kai-Yan; Chen, Shan-Shan; Jiang, Bin; Jiang, Hao; Chen, Huan; Chen, Yu-Hong; Han, Wei; Zhang, Xiao-Hui; Wang, Yu; Qin, Ya-Zhen; Liu, Yan-Rong; Lai, Yue-Yun; Huang, Xiao-Jun |
| 2010 | Imatinib Mesylate Versus Allogeneic HSCT for Patients with Chronic Myelogenous Leukemia In Accelerated Phase: A Single Center Experience In China After a 9-Year Follow-up. | Jiang, Qian; Xu, Lan-Ping; Liu, Dai-Hong; Liu, Kaiyan; Chen, Shan-Shan; Jiang, Bin; Jiang, Hao; Chen, Huan; Chen, Yu-Hong; Han, Wei; Zhang, Xiao-hui; Wang, Yu; Qin, Ya-Zhen; Liu, Yan-Rong; Lai, Yue-yun; Huang, Xiao Jun |
| 2010 | MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation-negative chronic myeloproliferative disorders detected by a newly developed RQ-PCR based on Taq Man MGB probes | Ruan, Guo-Rui; Jiang, Bin; Li, Ling-Di; Niu, Ji-Hong; Li, Jin-Lan; Xie, Min; Qin, Ya-Zhen; Liu, Yan-Rong; Huang, Xiao-Jun; Chen, Shan-Shan |
| 2009 | Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia | Ruan, Guo-Rui; Li, Jin-Lan; Qin, Ya-Zhen; Li, Ling-Di; Xie, Min; Chang, Yan; Zhang, Yan; Liu, Yan-Rong; Jiang, Bin; Chen, Shan-Shan; Huang, Xiao-Jun |
| 2016 | Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia | Yao, Qiu-Mei; Liu, Kai-Yan; Gale, Robert Peter; Jiang, Bin; Liu, Yan-Rong; Jiang, Qian; Jiang, Hao; Zhang, Xiao-Hui; Zhang, Mei-Jie; Chen, Shan-Shan; Huang, Xiao-Jun; Xu, Lan-Ping; Ruan, Guo-Rui |
| 2015 | A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms | Yao, Qiu-Mei; Zhou, Jiao; Gale, Robert Peter; Li, Jin-Lan; Li, Ling-Di; Li, Ning; Chen, Shan-Shan; Ruan, Guo-Rui |
| 2011 | Seven-year response to imatinib as initial treatment versus re-treatment in Chinese patients with chronic myelogenous leukemia in the chronic phase | Jiang, Hao; Chen, Shan-Shan; Jiang, Bin; Jiang, Qian; Qin, Ya-Zhen; Lai, Yue-Yun; Huang, Xiao-Jun |
